67 related articles for article (PubMed ID: 16948177)
1. Systematic Review of Systemic Corticosteroids for Treatment of Organizing Pneumonia.
Cendon L; Rafecas Codern A; de la Rosa D; Castellví I; Spagnolo P; Castillo D
Open Respir Arch; 2022; 4(4):100211. PubMed ID: 37496960
[TBL] [Abstract][Full Text] [Related]
2. Rituximab-Induced Immune Dysregulation Leading to Organizing Pneumonia, Bronchiectasis, and Pulmonary Fibrosis.
Ayyad M; Azar J; Albandak M; Sharabati H; Salim H; Jaber Y; Al-Tawil M
Cureus; 2023 Feb; 15(2):e34798. PubMed ID: 36915836
[TBL] [Abstract][Full Text] [Related]
3. Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report.
Aysan N; Köybaşı G; Satıcı C; Demirkol MA; Arpınar Yiğitbaş B; Arpaçağ Koşar AF
Tuberk Toraks; 2023 Mar; 71(1):107-111. PubMed ID: 36912415
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for steroid-resistant organising pneumonia in a woman with rheumatoid arthritis.
Loftis CE; Dulgheru E; Kaplan A
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36319035
[TBL] [Abstract][Full Text] [Related]
5. Rituximab-induced interstitial lung disease: five case reports.
Naqibullah M; Shaker SB; Bach KS; Bendstrup E
Eur Clin Respir J; 2015; 2():. PubMed ID: 26557260
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody therapy and renal transplantation: focus on adverse effects.
Zaza G; Tomei P; Granata S; Boschiero L; Lupo A
Toxins (Basel); 2014 Feb; 6(3):869-91. PubMed ID: 24590384
[TBL] [Abstract][Full Text] [Related]
7. Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective.
Kasi PM; Tawbi HA; Oddis CV; Kulkarni HS
Crit Care; 2012 Aug; 16(4):231. PubMed ID: 22967460
[TBL] [Abstract][Full Text] [Related]
8. Rituximab-induced bronchiolitis obliterans organizing pneumonia.
Ergin AB; Fong N; Daw HA
Case Rep Med; 2012; 2012():680431. PubMed ID: 22778751
[TBL] [Abstract][Full Text] [Related]
9. Cryptogenic organizing pneumonia due to amiodarone: long-term follow-up after corticosteroid treatment.
Schindler K; Schima W; Kaliman JF
Wien Klin Wochenschr; 2010 Aug; 122(15-16):511-4. PubMed ID: 20668958
[TBL] [Abstract][Full Text] [Related]
10. A case of organizing pneumonia associated with rituximab.
Maeng CH; Chin SO; Yang BH; Kim SY; Youn HJ; Cho KS; Baek SK; Lee S
Cancer Res Treat; 2007 Jun; 39(2):88-91. PubMed ID: 19746217
[TBL] [Abstract][Full Text] [Related]
11. Neglected respiratory toxicity caused by cancer therapy.
Domingo C; Roig J
Open Respir Med J; 2007; 1():1-6. PubMed ID: 19340316
[TBL] [Abstract][Full Text] [Related]
12. Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.
Vahid B; Marik PE
Can Respir J; 2008; 15(4):211-6. PubMed ID: 18551203
[TBL] [Abstract][Full Text] [Related]
13. Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma.
Biehn SE; Kirk D; Rivera MP; Martinez AE; Khandani AH; Orlowski RZ
Hematol Oncol; 2006 Dec; 24(4):234-7. PubMed ID: 16948177
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
15. Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy.
Maeshima AM; Taniguchi H; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
Cancer Sci; 2009 Jan; 100(1):54-61. PubMed ID: 19038008
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma.
Shortt J; Spencer A
Bone Marrow Transplant; 2006 Sep; 38(6):433-6. PubMed ID: 16892074
[TBL] [Abstract][Full Text] [Related]
17. Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's lymphoma.
Bonavida B; Vega MI
Drug Resist Updat; 2005; 8(1-2):27-41. PubMed ID: 15939340
[TBL] [Abstract][Full Text] [Related]
18. [Rituximab in the treatment of indolent non-Hodgkin's lymphoma].
Aurer I; Mitrović Z; Radman I; Kovacević-Metelko J; Nemet D; Serventi-Seiwerth R; Stern-Padovan R; Jakic-Razumović J; Nola M; Zupancić-Salek S; Sertić D; Labar B
Lijec Vjesn; 2004; 126(11-12):307-11. PubMed ID: 16082888
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
